ICD-10 Specific code G47.4: Narcolepsy and cataplexy
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Narcolepsy and cataplexy |
French
|
Narcolepsie et cataplexie |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | VI | Diseases of the nervous system | |
| 2 | G40-G47 | Episodic and paroxysmal disorders | |
| 3 | G47 | Sleep disorders | |
| 4 | G47.4 | Narcolepsy and cataplexy |
Indicated medicines
| Active Ingredient |
|---|
|
Modafinil promotes wakefulness in a variety of species, including man. The precise mechanism(s) through which modafinil promotes wakefulness is unknown. |
|
Sodium oxybate is a central nervous system depressant which reduces excessive daytime sleepiness and cataplexy in patients with narcolepsy and modifies sleep architecture reducing fragmented nighttime sleep. The precise mechanism by which sodium oxybate produces an effect is unknown, however sodium oxybate is thought to act by promoting slow (delta) wave sleep and consolidating night-time sleep. |